Inventor · disambiguated record
Antonino Cattaneo
Also filed as: CATTANEO ANTONINO
10 granted patents·11 pending applications·138 citations·filing 2000–2022
90Inventor score
Files withCATTANEO ANTONINO7LAY LINE GENOMICS SPA3SCUOLA NORMALE SUPERIORE2ABBVIE RES B V1CHIESI FARM SPA1
Top patents by PatentIndex Score
21 records- 0190US8257710B2Method for the treatment of pain with humanized anti-nerve growth factor antibodiesCATTANEO ANTONINO·Filed 2010·Granted Sep 4, 2012·18 cites·11 claims
- 0290US8246956B2Humanized anti-nerve growth factor antibodiesCATTANEO ANTONINO·Filed 2010·Granted Aug 21, 2012·16 cites·11 claims
- 0389US7988966B2Method for the potentiation of opioid analgesics effects on painLAY LINE GENOMICS SPA·Filed 2006·Granted Aug 2, 2011·23 cites·21 claims
- 0485US8296079B2Method for the humanization of antibodies and humanized antibodies thereby obtainedCATTANEO ANTONINO·Filed 2004·Granted Oct 23, 2012·21 cites·4 claims
- 0585US7897347B2Selection of intracellular immunoglobulinsMEDICAL RES COUNCIL·Filed 2009·Granted Mar 1, 2011·16 cites·8 claims
- 0683US7608453B2Intracellular antibodiesMRC SISSA SCUOLA INTERNAZ SUPE·Filed 2004·Granted Oct 27, 2009·40 cites·2 claims
- 0766US9688749B2Molecules that are able to inhibit the binding between NGF and the TrkA receptor as analgesics with prolonged effectPAVONE FLAMINIA·Filed 2006·Granted Jun 27, 2017·1 cites·20 claims
- 0860US2014316113A1Method for the humanization of antibodies and humanized antibodies thereby obtainedLAY LINE GENOMICS SPA·Filed 2014·Application pending·0 cites
- 0959US2024393350A1Method for the early diagnosis of neurodegenerative diseases by means of quantification of prongf and derived forms thereofEUROPEAN BRAIN RES INSTITUTE EBRI R LEVI MONTALCINI·Filed 2022·Application pending·0 cites
- 1056US2015218264A1Methods for the humanization of antibodies and humanized antibodies thereby obtainedABBVIE RES B V·Filed 2014·Application pending·0 cites
- 1155US8877491B2Polynucleotides encoding humanized anti-NGF antibodiesCATTANEO ANTONINO·Filed 2010·Granted Nov 4, 2014·0 cites·6 claims
- 1255US2022065850A1Intrabodies targeting post-translational modifications of native proteins and method for obtaining themSCUOLA NORMALE SUPERIORE·Filed 2021·Application pending·0 cites
- 1352US2011105727A1Method for the humanization of antibodies and humanized antibodies thereby obtainedLAY LINE GENOMICS SPA·Filed 2010·Application pending·0 cites
- 1451US2020339647A1Inhibitor of astrocyte tnf alpha for use in the treatment of neurological diseasesCATTANEO ANTONINO·Filed 2020·Application pending·0 cites
- 1550US7273964B1Non-human transgenic animals for the study of neurodegenerative syndromesSCUOLA INTERNAZ SUPERIORE DI S·Filed 2000·Granted Sep 25, 2007·3 cites·12 claims
- 1650US2006257925A1Method for isolating intracellular antibodies able to neutralize protein interactionsLINE GENOMICS S P A·Filed 2003·Application pending·0 cites
- 1743US11137393B2Intrabodies targeting post-translational modifications of native proteins and method for obtaining themSCUOLA NORMALE SUPERIORE·Filed 2016·Granted Oct 5, 2021·0 cites·9 claims
- 1842US2003235850A1Method for in vivo identification of intracellular epitopesFiled 2003·Application pending·0 cites
- 1941US2018086805A1proNGF mutants and uses thereof for the preparation of NGF mutantsCHIESI FARM SPA·Filed 2017·Application pending·0 cites
- 2037US2019092825A1Inhibitor of astrocyte tnf alpha for use in the treatment of neurological diseasesCATTANEO ANTONINO·Filed 2017·Application pending·0 cites
- 2133US2007253907A1Non Human Transgenic Animal as Model of Neurodegenerative Diseases and for the Early Diagnosis ThereofCATTANEO ANTONINO·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Antonino Cattaneo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →